Back
Design Therapeutics Stock Price Chart
The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.
Sell
25
DSGN
Design Therapeutics
Last Price:
$3.99
Seasonality Move:
-7.13%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
The current trend is moderately bullish and DSGN is experiencing selling pressure, which indicates risk of future bearish movement.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.99 | Buy |
| 20-day SMA: | 3.75 | Buy |
| 50-day SMA: | 3.74 | Buy |
| 200-day SMA: | 4.9 | Sell |
| 8-day EMA: | 3.96 | Buy |
| 20-day EMA: | 3.86 | Buy |
| 50-day EMA: | 3.4 | Buy |
| 200-day EMA: | 1.61 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 53.85 | Buy |
| Chaikin Money Flow: | -95904 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.45 - 4.11) | Buy |
| Bollinger Bands (100): | (3.58 - 4.84) | Sell |
Design Therapeutics Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.01 while DSGN 8-day simple moving average is 3.99, which is a Buy signal.
-
The stock price of DSGN is 4.01 while Design Therapeutics 20-day SMA is 3.75, which makes it a Buy.
-
Design Therapeutics 50-day simple moving average is 3.74 while DSGN share price is 4.01, making it a Buy technically.
-
DSGN stock price is 4.01 and Design Therapeutics 200-day simple moving average is 4.90, creating a Sell signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
25
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a SellThe current Design Therapeutics [DSGN] share price is $4.01. The Score for DSGN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
227.6M
Price in USD:
4.01
Share Volume:
119.2K
Design Therapeutics 52-Week Range
52-Week High:
7.77
52-Week Low:
2.60
Sell
25
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?The Design Therapeutics stock price is 4.01 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.01 while DSGN 8-day exponential moving average is 3.96, which is a Buy signal.
-
The stock price of DSGN is 4.01 while Design Therapeutics 20-day EMA is 3.86, which makes it a Buy.
-
Design Therapeutics 50-day exponential moving average is 3.40 while DSGN share price is 4.01, making it a Buy technically.
-
DSGN stock price is 4.01 and Design Therapeutics 200-day simple moving average is 1.61, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and an increase next year of $0.10 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is 0.13, suggesting Design Therapeutics is a Buy
-
Design Therapeutics Relative Strength Index (RSI) is 53.85, which suggest Design Therapeutics is overbought
-
The Bollinger Bands (25) for Design Therapeutics is (3.45 - 4.11), which suggest Design Therapeutics is a Sell
-
The Bollinger Bands (100) for Design Therapeutics is (3.58 - 4.84), which suggest Design Therapeutics is a Sell
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.